Test 5-Parkinson’s, Vestibular, CNS Degen. Dz, Etc. Flashcards
Def: An autoimmune disorder characterized by sclerotic plaques throughout the CNS that block or slow neural transmission resulting in weakness, sensory loss, visual dysfunction and other symptoms depending on where the plaques develop in the CNS. It is a disease of the temperate climates such as zones of North America, Europe, Canada, Australia and New Zealand
Multiple Sclerosis
Onset of MS is at ___-___ y.o. with whites at greater risk
Co-existing autoimmune disorders are seen in a majority of patients with MS, such as Hashimoto’s dz, _____, IBS, and RA. ______ infection often precipitates an attack of MS.
20-40
Psoriasis
Viral
S&S of MS: -80% have ____ symptoms, often double vision, sometimes develop optic ______ (inflammation of optic nerve)
- Sensory changes (paresthesias, vibratory sense)
- Muscle weakness- result of ______
- Lack of _______ and balance
- Gait deviations
- Fatigue!
- Cognitive impairment & depression
- Spasticity
Visual
Optic neuritis
Demyelination
Coordination
Diagnosis of MS:
- History
- Neurological exam
- _____
- ______ puncture
MRI
Lumbar puncture
(MS) Management of Acute Relapses: \_\_\_\_\_\_\_\_\_ therapy (methylprednisolone)- anti inflammatory and immunosuppressive effects \_\_\_\_\_ swelling in CNS and decrease T-cell activation. Side effects of meds: Mood changes, elevated \_\_\_\_, fluid retention, hyperglycemia. Chronic use associated with \_\_\_\_\_\_\_, DM, osteopenia.
Corticosteroid
Decrease
BP
HTN
Disease modifying therapeutic agents (MS) : Goal is to prevent future disease activity. Synthetic interferon drugs slow down ______ system response by decreasing inflammation and slowing proliferation of T and B cells.
Side effects- injection site reactions, ___-like symptoms.
Immune
Flu-like
Clinical Subtypes of MS:
_____-_____ (85%) : Periods of exacerbations (relapse) followed by full or partial recovery (remission). Periods between relapses- no dz progression.
_____ _____: Relapsing-remitting course followed by progressive, irreversible decline
_____-_____: no discrete attacks, steady progression of disease
Relapsing-remitting
Secondary Progressive
Primary-Progressive
Def: Progressive disorder of CNS affecting the basal ganglion (loss of dopamine) Has insidious onset with slow rate of progression.
Parkinson’s disease
Motor symptoms from Parkinson’s disease:
Rigidity- increased resistance to passive motion; 2 types:
1) _____- extremity catches
2)_____- stiff
“_______” tremor- seen at rest
Cogwheel rigidity
Lead pipe rigidity
“Pill-rolling” tremor
Def: slow to move
motor symptom of Parkinson’s
Bradykinesia
Non-motor symptoms of PD:
- Loss of ____
- Sleep disturbance
- Mood disorders
- Orthostatic ______
- Bladder dysfunction
- Difficulty _____/______
- Confusion, _______
Smell
Hypotension
Speaking/swallowing
Dementia
Etiology of PD:
Combination of _____, ______, and ______ influences
Genes, environment, and lifestyle influences
Function of basal ganglia:
Helps to plan, initiate, and control movements
Potential Protective Factors (PD):
- Caffeine
- High _____ acid levels in men
- _________ drugs
- Statins
- Vitamin ___
- Exercise
Uric acid
Anti-inflammatory
Vit D
Early warning signs of PD:
- Tremor or shaking
- Small handwriting (sudden change)
- Loss of smell (foods like bananas, dill pickles, licorice)
- Trouble sleeping (thrashing, falling out of bed)
- Trouble moving or walking (stiffness, arms don’t swing)
- Constipation
- Soft or low voice
- Masked face (serious/mad looking)
- Dizziness or fainting (due to low BP)
- Stooping or hunching
Pharmacology (PD):
_____/_____ (Sinemet) - pt needs to be on a fixed schedule
Benefits: Bradykinesia, rigidity
Side effects: Hallucinations, depression, insomnia
**High ____ diet can alter effects
Levodopa/Carbidopa
Protein
Deep Brain Stimulation (for PD):
[Thalamic/Subthalamic stimulation]
Benefits- Helps control _____
Side effects- More difficulty _____
Control tremors
Difficulty Walking
Typical cause of death in people with Parkinson’s:
Respiratory related
Interventions for PD:
Pg664 pathology
Improving movement-
- Walking sideways
- Rocking body to generate weight shift
- Stamping feet, shaking legs
- Self-talk
- Stepping over objects (handle of cane, etc)
- Quick head movements
- Music
- Clapping/snapping
- VR
Interventions for PD:
Big red pg788-789
-Simple blocked practice tasks with many repetitions
-Have pt focus on their movements (use mirrors)
Ex. Have patient focus on swinging their arms during gait, or walk fast, or take large steps
-Visual cues important (tape, laser,etc)
- RAS (Rhythmic auditory Stimulation), metronome, music with steady beat; can help improve gait speed, cadence, and stride
Interventions for PD (cont):
Look at of 793-7796 Big Red
- BIG movements with whole body, repetitive, high intensity
- Flexibility Ex. (PROM & AROM)
- Additional VC and TC to encourage maximum range
- Strength training
- -Functional training (bridging, pelvic tilts, rolling, sit-stands, quadruped-kneeling-half kneeling-standing)
- Balance training
(Subtype of MS) - First episode of inflammatory demyelinating of CNS that could become MS if additional activity occurs. Not active= no clinical Relapses or new MRI activity
Active= With relapses or new evidence on MRI in which case it becomes relapsing remitting
Clinically Isolate Syndrome
Treatment for MS:
-Alternate days, during optimal times such as in the ______ when core body temp is lowest.
-Balance exercise with rest breaks to AVOID _______! Ex. to point of fatigue is a contraindication.
-Group ex valuable motivation
-Strengthening, aerobic 3 days/week (alternate days) walking, _______, swimming
Prevent patient from _________.
AVOID OVERWORK
cycling or water aerobics
*also gait training, flexibility, balance, spasticity mgmt
What kind of approach is essential for patients with MS?
Team approach!
Def: Terminal progressive disease; loss of motor neurons in lateral spinal cord, brainstem and motor cortex. Onset mid to late 50s; asymmetrical weakness in arm or leg usually begins distally and moves proximally. Weakness of bulbar (facial) muscles, causing dysphagia. Effects extensor mm more than flexors. Fasciculations of muscles (random twitching, muscle cramps)
ALS (Amyotrophic Lateral Sclerosis)
Diagnosis of ALS:
Presence of ____ and ____ findings
-weakness, atrophy, fatigue, hyperreflexia
-EMG changes (fibrillations and fasciculations)
Prognosis: Death usually occurs within __-__ years post dx, typically due to _______ complications.
UMN and LMN
2-5 yrs
Respiratory complications
PT for ALS patients: Early stage ALS- \_\_\_\_\_\_\_ resistance can increase strength in mm grade 3/5 or higher. Avoid heavy \_\_\_\_\_ exercise. Avoid heavy \_\_\_\_\_\_ or \_\_\_\_\_ reps. Review pg. 733 in Big Red
Moderate
Eccentric
Heavy Resistance or high reps
Def: Neurodegenerative genetic disorder—autosomal dominant inheritance; fatal disease. Dominated by involuntary, sustained muscle contractions frequently causing twisting and repetitive movements and abnormal postures. Marked loss in brain volume.
Huntington’s disease
S&S of Huntington’s:
- ______ (Jerky, random and uncontrolled movements)
- Depression
- _______
- Psychiatric disorders
Chorea
Dementia
Medical Management of Huntington’s Dz:
- family history, DNA samples, MRI of brain
- Treating symptoms
- Pharmacological mgt of chorea available but side effects include pseudoparkinsonism, akinesia, restlessness
*prognosis of death on avg 15-20 years post onset. Increasing disability and mental changes
PT interventions (Huntington’s):
- safety
- gait
- freezing during gait can occur
- ADL training
- DME
4 types of dizziness:
_______: Room is spinning around the patient
______: Woozy, disconnected from environment
_____: Feels unsteady, off-balance
_____: Precursor to fainting, feeling of about to lose consciousness
Vertigo
lightheadedness
Disequilibrium
Pre-syncope
2 types of vertigo-associated disorders:
Central (Brain, brain stem or cerebellum)
Peripheral (Semicircular canal or vestibular nerve)
Which type of vertigo-associated disorder?
(Central or peripheral)
-Blood vessel disease, MS, seizures, CVA, tumors, vestibular migraine. Meds: Anticonvulsants, ASA, ETOH
Central